JCM | Free Full-Text | Thinking Outside the Ischemia Box: Advancements in the Use of Multiple Sclerosis Drugs in Ischemic Stroke
Transitioning Teva revamps branding to emphasize brand-generic unity | Fierce Pharma
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Neurology
Teva recalls 2 lots of hypertension drug on dissolution issues
Uninhibited' price hikes, lobbying and more: Congressional probe gives detailed look into Teva's long run with Copaxone | Fierce Pharma
Teva at the Top of Generics - The Israel High Tech & Investment ...
JCM | Free Full-Text | Concomitant Acute Ischemic Stroke and Upper Extremity Arterial Occlusion: Feasibility of Mechanical Thrombectomy of the Upper Limb Using Neurointerventional Devices and Techniques
Teva's Huntington drug launch on hold after FDA rejection | Fierce Biotech
Teva Recalls One Lot Of Topotecan Injection
Teva's Digihaler linked to improved asthma control in trial
Frontiers | Hyperdense Artery Sign in Patients With Acute Ischemic Stroke–Automated Detection With Artificial Intelligence-Driven Software
Atrial fibrillation in cryptogenic stroke and TIA patients in The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Main results - B Ratajczak-Tretel, A Tancin Lambert, R Al-Ani, K Arntzen, GK Bakkejord, HMO
Overactive Bladder Treatment Market – Global Industry Trends and Forecast to 2029 | Data Bridge Market Research
Pharmaceutics | Free Full-Text | Advances in Antibody-Based Therapeutics for Cerebral Ischemia
CNS Therapeutics Market Growth-Regions 2022 Research Scope by Fu - NEWS CHANNEL NEBRASKA
Teva wins FDA nod for sublingual film to treat opioid dependence - Drug Delivery Business
Intravenous Thrombolysis in Patients With Ischemic Stroke Aged ≥90 Years: A Cohort Study From the TRISP Collaboration | Stroke
FDA announces recall of platelet-reducing medication due to risk of clotting or other adverse cardiovascular outcomes
Dual Antiplatelet Therapy Increases Hemorrhagic Transformation Following Thrombolytic Treatment in Experimental Stroke | Stroke
Teva Launches Honestly HD Website to Provide People Living With Huntington's Disease (HD) Information, Inspiration and Resources on HD Chorea
FDA Receives Resubmission of the Apixaban Drug Application to Reduce Stroke in Patients With Atrial Fibrillation | DAIC
